Premium
Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic response
Author(s) -
Frankfurt Oskar S.,
Seckinger Daniel,
Sugarbaker Everett V.
Publication year - 1994
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910590214
Subject(s) - apoptosis , drug resistance , biology , immunology , drug , cancer research , leukemia , drug response , microbiology and biotechnology , pharmacology , genetics
Abstract Cell line R9 generated by continuous exposure of MOLT‐4 cells to adriamycin was cross‐resistant to a variety of unrelated drugs. The following data indicate that diminished apoptotic response was the mechanism of acquired pleiotropic drug resistance: (i) apoptosis was a common mechanism of cell death for agents expressing cross‐resistance; (ii) induction of apoptosis by drugs, medium depletion and serum deprivation was decreased in R9 cells; (iii) DNA degradation in apoptotic cells was lower in resistant lines, probably reflecting, a modification of apoptotic pathway in resistant cells; (iv) inhibition of cell division and DNA synthesis by drugs was similar in sensitive and resistant cells. These data indicated a similar level of initial damage, as typical for resistance based on modified apoptotic response. There was no difference in bcl ‐2 protein level between sensitive and resistant cells. Thus acquired pleiotropic resistance and diminished apoptotic response in R9 cells were induced by a bcl ‐2‐independent mechanism. Surface T‐cell antigen CD4 was expressed in MOLT‐4 and lost in R9 cells. The role of CD4 down‐regulation in apoptosis‐related drug resistance remains to be explored. The association between acquired pleiotropic drug resistance and increased survival capacity in unfavorable growth conditions indicated that drug‐induced selection of cells with diminished apoptotic response may stimulate neoplastic progression. Alkylating agents induced similar cytotoxicity and only slightly lower apoptosis in R9 cells in comparison with MOLT‐4 cells. Our data show that some drugs may overcome acquired pleiotropic drug resistance based on the modified apoptotic pathway.